MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,029K
Free Cash flow
-$7,459K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of ordina...
Accrued expenses
Other
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other curre...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-8,979
-11,400
Depreciation
6
13
Amortization of intangible asset
349
687
Share-based compensation expense
53
117
Interest on short-term investments
0
0
Amortization of debt discount and deferred financing costs
0
194
Interest on notes - non-cash-Exchangeable Senior Subordinated Notes Due Two Thousand Twenty Five
0
88
Financing transaction costs included in financing activities
0
-
Interest on notes - non-cash-Promissory Note
562
853
Adjustments to fair value of derivatives
-673
-1,134
Other
-880
-940
Accounts receivable
448
-
Prepaid expenses and other current assets
984
1,212
Inventory
201
948
Accounts payable
-612
938
Accrued expenses
1,343
1,299
Income taxes
-89
54
Other liabilities
0
-568
Net cash used in operating activities
-7,447
-7,811
Purchases of property and equipment
12
2
Purchases of short-term investments
0
0
Proceeds from sale of short-term investments
0
0
Net cash (used in) / provided by investing activities
-12
-2
Repayment of exchangeable notes
0
14,745
Proceeds from issuance of ordinary shares, net of transaction costs
5,432
11,477
Net cash provided by financing activities
5,432
-3,268
Effect of exchange rates on cash and cash equivalents
-2
-18
Net (decrease) / increase in cash, cash equivalents and restricted cash
-2,029
-11,099
Cash and cash equivalents at beginning of period
24,159
-
Cash and cash equivalents at end of period
11,031
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
ordinary shares, net of...
$5,432K
Net cash provided by
financing activities
$5,432K
Net (decrease) /
increase in cash, cash...
-$2,029K
Canceled cashflow
$5,432K
Accrued expenses
$1,343K
Other
-$880K
Adjustments to fair value of
derivatives
-$673K
Interest on notes -
non-cash-Promissory Note
$562K
Amortization of intangible
asset
$349K
Share-based compensation
expense
$53K
Depreciation
$6K
Net cash used in
operating activities
-$7,447K
Canceled cashflow
$3,866K
Net cash (used in) /
provided by investing...
-$12K
Effect of exchange
rates on cash and cash...
-$2K
Net loss
-$8,979K
Prepaid expenses and
other current assets
$984K
Accounts payable
-$612K
Accounts receivable
$448K
Inventory
$201K
Income taxes
-$89K
Purchases of property and
equipment
$12K
Buy us a coffee
Iterum Therapeutics plc (ITRM)
Iterum Therapeutics plc (ITRM)